Krishna Institute of Medical Sciences Limited

NSEI:KIMS Stock Report

Market Cap: ₹163.7b

Krishna Institute of Medical Sciences Past Earnings Performance

Past criteria checks 2/6

Krishna Institute of Medical Sciences hat die Erträge mit einer durchschnittlichen jährlichen Rate von 27.8% gesteigert, während die Branche Healthcare die Erträge growing mit 29.1% jährlich steigerte. Die Einnahmen sind growing mit einer durchschnittlichen Rate von 19.7% pro Jahr gestiegen. Krishna Institute of Medical Sciences Die Eigenkapitalrendite des Unternehmens beträgt 17.4%, und die Nettomargen liegen bei 13.8%.

Key information

27.8%

Earnings growth rate

26.5%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate19.7%
Return on equity17.4%
Net Margin13.8%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Feb 29
Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 08
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Jan 23
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Nov 21
Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Aug 23
Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Aug 02
Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Apr 01
Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Dec 14
Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Aug 13
Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Aug 12
Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Jul 02
Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

May 08
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

Revenue & Expenses Breakdown
Beta

How Krishna Institute of Medical Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NSEI:KIMS Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2324,4033,3793520
30 Sep 2323,9663,4213520
30 Jun 2323,0823,4723520
31 Mar 2321,9773,3633520
31 Dec 2219,9413,2372580
30 Sep 2218,2553,2892580
30 Jun 2216,7323,1352580
31 Mar 2216,5083,3272050
31 Dec 2116,3703,0981870
30 Sep 2116,0412,7741870
30 Jun 2116,0202,7921870
31 Mar 2113,2992,0121870
31 Dec 2012,4121,7211760
31 Mar 2011,2271,1921680
31 Mar 199,204-4772200
31 Mar 186,652-4741180
31 Mar 175,6893261,7230
31 Mar 165,1452661,5750
31 Mar 154,222561,3070
31 Mar 143,56969350

Qualität der Erträge: KIMS hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: KIMSDie aktuellen Gewinnspannen (13.8%) sind niedriger als im letzten Jahr (16.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Ergebnisentwicklung: KIMS ist in den letzten 5 Jahren profitabel geworden und hat seinen Gewinn um 27.8% pro Jahr gesteigert.

Beschleunigtes Wachstum: KIMSDas Gewinnwachstum des Unternehmens im letzten Jahr (4.4%) liegt unter seinem 5-Jahres-Durchschnitt (27.8% pro Jahr).

Erträge im Vergleich zur Industrie: KIMS Das Gewinnwachstum im vergangenen Jahr (4.4%) übertraf nicht die Entwicklung der Branche Healthcare 28% .


Return on Equity

Hohe Eigenkapitalrendite: KIMSDie Eigenkapitalrendite des Unternehmens (17.4%) wird als niedrig angesehen.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.